ESC Congress 2004: ICTUS study shows no benefit from early PCI/CABG in high risk unstable angina

August 29, 2004

Patients with chest pain are recognized as being at high risk of subsequent adverse cardiac events when their plasma levels of cardiac troponin are elevated as evidence of myocardial damage. Based on earlier studies, ESC and ACC/AHA guidelines recommend early angiography and PCI or CABG (early invasive strategy) in all these high risk patients. Dutch clinical investigators will present data during the Hotline II session on Sunday afternoon, August 29th, showing that modern medical treatment, and angiography followed by PCI or CABG in selected patients (selective invasive strategy), may be equally effective.

Study design

Patients were eligible when presenting with chest pain within 24 hours, an elevated cardiac troponin T and either ischemic electrocardiographic changes or a documented history of coronary artery disease. From July 2001 to August 2003, 1200 patients were randomized between an early invasive treatment strategy that included coronary angiography within 24-48 hrs, PCI within 48 hrs or CABG as soon as possible; or a selective invasive strategy that included medical stabilization and angiography and revascularization only in case of refractory angina or ischemia on pre-discharge exercise testing.

Background therapy included aspirin, enoxaparin for at least 48 hours, beta-blockers, nitrates, clopidogrel, high dose statin therapy (80mg atorvastatin or equivalent), and abciximab at the time of all percutaneous coronary intervention. All revascularization procedures were done at one of the 12 participating high volume intervention centers. The primary endpoint was the combination of death, myocardial infarction or rehospitalization for acute coronary syndrome at one year.

Mortality was only 2% in ICTUS, considering these were high risk troponin-positive patients. There were significantly more myocardial infarctions in the early invasive strategy compared to the selective invasive strategy: 14.6% versus 9.4%. However, the number of rehospitalizations was higher in the selective invasive group. Thus, the outcome was comparable between the two treatment strategies, albeit with 25% less invasive procedures in the selective invasive treatment group.

The ICTUS investigators conclude that their study shows that early invasive and selective invasive strategies are equivalent treatment options in patients with nSTE-ACS and an elevated cardiac troponin. The findings in ICTUS challenge the current ESC and ACC/AHA guidelines on the management of nSTE-ACS patients.
Prof RJ De Winter (Amsterdam, NL)

This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2004. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology

European Society of Cardiology

Related Chest Pain Articles from Brightsurf:

New approach helps EMTs better assess chest pain en route to hospital
A study conducted at Wake Forest Baptist Health shows that on-scene use of a new protocol and advanced diagnostic equipment can help paramedics better identify patients at high risk for adverse cardiac events.

Brain activity during psychological stress may predict chest pain in people with heart disease
The brain's reaction to stress could be an important indicator of angina (chest pain) among people with known heart disease.

Chest pain, stress tests warrant attention even if arteries are clear
Patients who experience chest pain and have abnormal results on a cardiac stress test but who do not have blocked arteries often experience changes in their symptoms and stress test results over time, according to research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

Women carry heavier burden of chest pain, but less artery narrowing
Women with coronary artery disease that reduces blood flow and oxygen to the heart muscle (ischemia) have significantly more chest pain caused by plaque build-up, yet less extensive disease as compared with men, according to new research presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology (ACC.20/WCC).

More isn't better when it comes to evaluating chest pain
New and more effective tests are needed to help predict heart attacks and other major cardiac events in patients with chest pain, the second most common reason for emergency department visits in the US.

Artificial intelligence could prevent unneeded tests in patients with stable chest pain
Artificial intelligence (AI) could prevent unnecessary diagnostic tests in patients with stable chest pain, according to research presented today at ICNC 2019.

Kaiser Permanente improves emergency care for patients with chest pain
Emergency physicians at Kaiser Permanente hospitals in Southern California reduced hospital admissions and cardiac stress testing by using new criteria to assess the level of risk patients with chest pain have for subsequent cardiac events.

Treatment for underdiagnosed cause of debilitating chest pain
Researchers find an effective way to treat an underdiagnosed condition that can cause heart attack and heart-attack-like symptoms.

Diagnostic protocol effective in identifying ED patients with acute chest pain
A relatively new accelerated diagnostic protocol is effective in identifying emergency department patients with acute chest pain who can be safely sent home without being hospitalized or undergoing comprehensive cardiac testing, according to researchers at Wake Forest Baptist Medical Center.

Chest pain drug falls short in preventing first episode of ventricular arrhythmia or death
A trial of more than 1,000 patients with implantable cardioverter defibrillators found that the drug ranolazine (used to treat chest pain; brand name Ranexa®) was safe but didn't decrease the likelihood of the first occurrence of ventricular arrhythmias or death in this high-risk population.

Read More: Chest Pain News and Chest Pain Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to